Armstrong Advisory Group’s Moderna MRNA Stock Holding History

Armstrong Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.4K	Hold	263	–	–	﹤0.01%	607
2026 Q1	$13.4K	Hold	263	–	–	﹤0.01%	636
2025 Q4	$7.76K	Hold	263	–	–	﹤0.01%	718
2025 Q3	$6.79K	Hold	263	–	–	﹤0.01%	735
2025 Q2	$7.26K	Hold	263	–	–	﹤0.01%	713
2025 Q1	$10.9K	Hold	263	–	–	﹤0.01%	605
2024 Q4	$10.9K	Sell	263 -100	-28%	-$4.78K	﹤0.01%	605
2024 Q3	$24.3K	Buy	363 +100	+38%	+$9.18K	﹤0.01%	473
2024 Q2	$31.2K	Buy	263 +51	+24%	+$6.45K	﹤0.01%	420
2024 Q1	$21.1K	Hold	212	–	–	﹤0.01%	473
2023 Q4	$21.1K	Hold	212	–	–	﹤0.01%	473
2023 Q3	$21.9K	Hold	212	–	–	﹤0.01%	470
2023 Q2	$25.8K	Hold	212	–	–	﹤0.01%	444
2023 Q1	$32.6K	Hold	212	–	–	﹤0.01%	396
2022 Q4	$38.1K	Buy	+212	New	+$34.7K	0.01%	371

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Armstrong Advisory Group's MRNA Position: Q2 2026 in Review

Armstrong Advisory Group held its Moderna (MRNA) position steady in Q2 2026 at 263 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #607.

Armstrong Advisory Group first reported a position in MRNA in Q4 2022 and has held it in 15 quarters since. The position peaked at $38.1K in Q4 2022. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Armstrong Advisory Group held 263 shares of Moderna worth $18.4K as of Q2 2026.
Armstrong Advisory Group left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #607 holding.
Armstrong Advisory Group first reported a position in Moderna in Q4 2022 and has held it in 15 quarters since.
Armstrong Advisory Group's Moderna position peaked at $38.1K in Q4 2022.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.